Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


Company developing software that helps physicians communicate with their patients. Their main product Chain SMS is used by medical office staff to send text messages for a variety of communications such as appointment reminders or to remind patients to take prescriptions.

The flagship product of accuRx is Chain SMS, a product used by GP practices to communicate with their patients. It is a self-service enterprise software product. Within 12 months following the launch of Chain SMS, in February 2018, it grew by referral from being used in 0% to 20% of GP practices in England.

Chain SMS is designed to support nurses, administration staff and practice managers etc., as well as GPs. Uses for Chain SMS include sending advice to patients, notifying a patient of normal results, and reminding them to book appointments. The communication is saved back to a patient's medical record .

Co-founders Jacob Haddad and Laurence Bargery met on Entrepreneur First. While Accurx initially set out to develop a data-set and tools to help tackle the problem of inappropriate use of antibiotics, the startup has pivoted to focus on creating a broader platform for communication between medical teams and patients.As of 2019 Accurx raised £8.8 million in Series A funding.


September 15, 2021
accuRx raises £27,500,000 in Series B funding round, led by Lakestar with participation from British Patient Capital, Latitude VS, Atomico, Trusted Insight and Encore Capital.
September 15, 2021
accuRx raises a $37,900,000 series B round.
March 28, 2019
Accurx raises £8.8M Series A for its messaging app for medical teams and patients

Accurx, the U.K. startup and Entrepreneur First alumni that has developed a messaging service for doctor surgeries, has raised £8.8 million in Series A funding, TechCrunch has learned.

February 2019
accuRx raises a $11,500,000 series A round from Atomico, Entrepreneur First and LocalGlobe.
February 2018
Chain SMS launched
accuRx was founded by Jacob Haddad and Laurence Bargery.

Funding Rounds


Further Resources



September 15, 2021
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Angelica Malin
May 12, 2021
Business Insider
Insider profiles 9 medtech startups that have investors' attention after the CEO of the London startup Huma predicted "the very beginning" of a revolution.


Golden logo
By using this site, you agree to our Terms & Conditions.